Novo Nordisk A/S – Page 2 – Finance Tailwind

European pharma secured a U.S. tariff win. Investors remain wary

FDA approves Signos glucose monitoring for weight loss

Viking Therapeutics falls 30% on drug data

Novo Nordisk offers diabetes drug Ozempic for steep cash discount

DAY, RUN, TSLA, NVO and more

Our top 3 gainers, laggards as the S&P 500 continues to hit records

We’re downgrading Lilly and asking ourselves tough questions after its obesity

Eli Lilly obesity pill orforglipron led to 12% weight loss

Hims & Hers (HIMS) Q2 earnings 2025

Trump asks drugmakers to cut U.S. prices within 60 days